Speaker: Carina Masferrer Ferragutcasas, Research technician, Biomedical Research in Gynaecology (VHIR)
Carina Masferrer Ferragutcasas earned her degree in Biomedical Sciences from the University of Barcelona (UB) and a Master’s in Translational Biomedical Research from the Autonomous University of Barcelona (UAB) and VHIR, when she joined the group led by Dr. Eva Colás. As part of her PhD, last year she completed a research stay at the Novo Nordisk Foundation Center for Protein Research (NNF-CPR) and the University of Copenhagen, further expanding her expertise in advanced proteomics techniques.  

Abstract: Endometriosis is a chronic, estrogen-dependent inflammatory disease that affects millions of women worldwide, often leading to pelvic pain and infertility. Current clinical staging does not correlate with clinical features of the disease, the pathophysiology of the condition is not well understood, and therapeutic options do not address the underlying causes of the disease. Up to 50% of patients experience lesion recurrence within five years of surgery, and there is no strategy to predict prognosis. Given the complexity and heterogeneity of the disease, advancing towards personalized medicine requires a deeper understanding of its molecular drivers.

Host: Dr. Eva Colas Ortega, Head of group, Biomedical Research in Gynaecology (VHIR)